IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q2 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6,915,818 | +6.0% | 1,094,275 | -10.0% | 0.00% | 0.0% |
Q1 2024 | $6,526,596 | +0.8% | 1,215,381 | -5.8% | 0.00% | 0.0% |
Q4 2023 | $6,476,493 | +795.9% | 1,290,138 | +201.6% | 0.00% | – |
Q3 2023 | $722,921 | -4.8% | 427,764 | +56.6% | 0.00% | – |
Q2 2023 | $759,274 | +18.0% | 273,120 | -22.8% | 0.00% | – |
Q1 2023 | $643,481 | -89.0% | 353,561 | -69.3% | 0.00% | -100.0% |
Q4 2022 | $5,839,240 | +207554.3% | 1,151,724 | +103.5% | 0.00% | 0.0% |
Q3 2022 | $2,812 | +32.4% | 565,843 | -0.9% | 0.00% | 0.0% |
Q2 2022 | $2,124 | -99.9% | 570,840 | +39.9% | 0.00% | – |
Q1 2022 | $2,290,000 | +43.9% | 408,175 | +56.0% | 0.00% | – |
Q4 2021 | $1,591,000 | -27.6% | 261,699 | +15.9% | 0.00% | – |
Q3 2021 | $2,199,000 | -21.6% | 225,747 | +14.9% | 0.00% | -100.0% |
Q2 2021 | $2,804,000 | +45.6% | 196,407 | +142.1% | 0.00% | – |
Q1 2021 | $1,926,000 | – | 81,142 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |